Implementation of universal screening for preterm delivery by mid-trimester cervical-length measurement.


Journal

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 09 09 2017
revised: 05 03 2018
accepted: 05 03 2018
pubmed: 15 3 2018
medline: 3 5 2019
entrez: 15 3 2018
Statut: ppublish

Résumé

To assess the feasibility and results of introducing a policy of universal screening for preterm delivery (PTD) by mid-trimester cervical-length (CL) measurement. In this retrospective cross-sectional study of singleton pregnancies, transvaginal sonography for CL measurement was performed at 20-24 weeks of gestation. Vaginal progesterone therapy was offered to women with CL ≤ 15 mm. The incidence of spontaneous PTD (sPTD) according to CL and the distribution of CL measurements were assessed. Rate of PTD before implementation of screening was compared with that after. A total of 10 506 singleton pregnancies were assessed. The decline rate was 1.32%. sPTD < 32 weeks, < 34 weeks and < 37 weeks occurred in 0.51%, 0.82% and 3.90% of pregnancies, respectively. CL measurement was best described by a mixture model distribution comprising a 'short' and a 'long' component. The percentage of the two components varied between subgroups of PTD, with the short component being greater the earlier the birth. CL, history of miscarriage, smoking status and prior PTD were independent predictors in the construction of a model predictive of PTD < 34 weeks (area under the curve = 0.74, P < 0.001). The rate of sPTD < 34 weeks in women with CL ≤ 15 mm receiving progesterone treatment was 20.4%. In the progesterone-treated group, a plateau was observed in the increase in risk for PTD for CL 9-13 mm, whereas below 9 mm the risk increased exponentially. Following the introduction of mid-trimester CL measurement, there was a trend for reduction in the rate of any PTD < 34 weeks of about 20% in comparison with the prescreening period (odds ratio = 0.81; 95% CI, 0.59-1.13). Universal screening for PTD by transvaginal sonographic measurement of CL at 20-24 weeks is feasible and well accepted by pregnant women. This policy identifies a very high-risk group that may benefit from intervention. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

Identifiants

pubmed: 29536576
doi: 10.1002/uog.19050
doi:

Substances chimiques

Progestins 0
Progesterone 4G7DS2Q64Y

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

396-401

Informations de copyright

Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

Auteurs

A P Souka (AP)

Fetal Medicine Unit, 3rd Department of Obstetrics and Gynaecology, University of Athens Medical School, 'Attikon' University Hospital, Athens, Greece.
Fetal Medicine Unit, Leto Maternity Hospital, Athens, Greece.

I Papastefanou (I)

Fetal Medicine Unit, 3rd Department of Obstetrics and Gynaecology, University of Athens Medical School, 'Attikon' University Hospital, Athens, Greece.
Fetal Medicine Unit, Leto Maternity Hospital, Athens, Greece.

A Pilalis (A)

Fetal Medicine Unit, 3rd Department of Obstetrics and Gynaecology, University of Athens Medical School, 'Attikon' University Hospital, Athens, Greece.
Fetal Medicine Unit, Leto Maternity Hospital, Athens, Greece.

D Kassanos (D)

Fetal Medicine Unit, 3rd Department of Obstetrics and Gynaecology, University of Athens Medical School, 'Attikon' University Hospital, Athens, Greece.

G Papadopoulos (G)

Laboratory of Biometry, Agricultural University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH